Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection using different tetracycline dosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth-containing quadruple therapy

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED